Objectives Fatigue is a significant issue in psoriatic arthritis. The objective was to assess the
effect of biological disease modifying antirheumatic drugs and apremilast on fatigue in …

Objective. Fatigue is one of the most significant symptoms, and an outcome of great
importance, in patients with psoriatic arthritis (PsA), but associations between underlying …

Background Fatigue is frequent in patients with psoriasis. Though conventional drugs in
general have no effect on fatigue, biological agents have demonstrated beneficial effects in …

Background A multitude of factors may influence fatigue in psoriasis and psoriatic arthritis
(PsA); however, their individual fatigue components have not been thoroughly examined …

Objectives Fatigue is an aspect of psoriatic arthritis (PsA), which is important to patients. The
objective was to evaluate magnitude of fatigue in PsA patients and to assess factors that …

Aim Fatigue is commonly associated with psoriatic arthritis (PsA). However, information
about its prevalence and associated factors is sparse. The primary objective here was to find …

Objectives To explore the prognostic value of pre-specified comorbidities on treatment
outcomes in PsA, and to compare baseline data with cutaneous psoriasis without arthritis …

Objective To test the addition of pain and fatigue to the Composite Psoriatic Arthritis Disease
Activity (CPDAI) and the Group for Research and Assessment of Psoriasis and PsA …

Objective. This pilot study examined sensitivity to change and relative independence of
fatigue as an outcome measure in patients with psoriatic arthritis (PsA) following anti-TNF …

Background Psoriatic arthritis is an inflammatory arthritis the primary manifestations of which
are locomotor and skin disease. Although a number of guidelines have been published …